Trilium Pharmaceuticals Private Limited
About Trilium Pharmaceuticals Private Limited
Data last updated:
Trilium Pharmaceuticals Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the speciality chemicals segment of the chemicals sector. It was incorporated on 03 June 2011.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2011PTC220309.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Rajesh Kumar and Nandini Sharma.
Its last annual general meeting (AGM) was held on 26 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at 4531 / 11 Jai Mata Market Tri Nagar, New Delhi, Delhi, India – 110035.
As per the financials filed for FY 2017, the company reported a revenue of ₹4.8 Lakh, a decline of 34% compared to the previous year. For the same year it recorded a net loss of ₹12,263 (net margin -2.6%) and EBITDA of ₹1,719 (EBITDA margin 0.4%). Revenue has declined at a compounded annual rate (CAGR) of 42% over three years.
Company details
Contact details
Trilium Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi.
- Registered Address4531 / 11 Jai Mata Market Tri Nagar, New Delhi, Delhi, India – 110035
- IndustryChemicals, Other Chemical Product, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Trilium Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Trilium Pharmaceuticals Private Limited, buy the company report.
Financials of Trilium Pharmaceuticals Private Limited
FY 2017 filings availableTrilium Pharmaceuticals Private Limited reported revenue of ₹4.8 Lakh (down 34% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 42% over three years, including a 34% fall in the latest year. EBITDA fell 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹1,719 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹12,263 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 0.4% | ||
| Net Profit Margin | -2.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Trilium Pharmaceuticals Private Limited, buy the company report.
Board of directors of Trilium Pharmaceuticals Private Limited
Trilium Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Kumar | Director | 03 Jun 2011 | 15 Years 5 Months | As last reported |
| Nandini Sharma | Director | 03 Jun 2011 | 15 Years 5 Months | As last reported |
Legal cases
No court or tribunal cases involving Trilium Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Trilium Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Trilium Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Trilium Pharmaceuticals Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Nandini Sharma was appointed as Director on 03 Jun 2011.
Frequently asked questions
Trilium Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Trilium Pharmaceuticals was a private limited company based in New Delhi, Delhi, India. The company worked in other chemical product, within the chemicals industry. It was incorporated on 03 June 2011 and is registered under CIN U24232DL2011PTC220309. The company has been struck off by the Registrar of Companies and is no longer operational.
Trilium Pharmaceuticals had 2 directors:
- Rajesh Kumar - Director
- Nandini Sharma - Director
The CIN (Corporate Identification Number) of Trilium Pharmaceuticals is U24232DL2011PTC220309. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Trilium Pharmaceuticals is at 4531 11 Jai Mata Market Tri Nagar, New Delhi, Delhi, India – 110035.
Trilium Pharmaceuticals was incorporated on 03 June 2011. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Trilium Pharmaceuticals on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 26 September 2017. Year-wise statements from 2015 are in the company report.
Trilium Pharmaceuticals operated in the chemicals industry, in the other chemical product segment. It worked in this industry before it was struck off.
Nandini Sharma was appointed as Director on 03 Jun 2011. Rajesh Kumar was appointed as Director on 03 Jun 2011.
The compliance status of Trilium Pharmaceuticals is active non-compliant as of 16 September 2026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
